Showing results (31-40 of 88) with videos related to
Sort By:
Pageof 9
Cancer|February 19, 2000
A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181N A Dawson, M Conaway, S Halabi, et al.The American Journal of Clinical Nutrition|May 1, 1997
Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapyW Demark-Wahnefried, V Hars, M R Conaway, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 1990
Improved survival in advanced Hodgkin's disease with the use of combined modality therapyD M Brizel, E P Winer, L R Prosnitz, et al.Cancer|October 8, 1998
Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient surveyM A Warmuth, G Bowen, L R Prosnitz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2013
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013A Goldhirsch, E P Winer, A S Coates, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2011
Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancerE M Olson, N U Lin, P J DiPiro, et al.Breast Cancer Research and Treatment|March 19, 2009
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancerE L Mayer, A H Partridge, L N Harris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2L G Bluman, B K Rimer, D A Berry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 studyP W Kantoff, S Halabi, M Conaway, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2015
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015A S Coates, E P Winer, A Goldhirsch, et al.Pageof 9